Skip to main content
Fig. 1 | BMC Microbiology

Fig. 1

From: In vitro activity of ceftaroline, ceftazidime-avibactam, and comparators against Gram-positive and -negative organisms in China: the 2018 results from the ATLAS program

Fig. 1

Fold MIC reduction of Gram-negative isolates by addition of avibactam to ceftazidime. eco: Escherichia coli; kpn: Klebsiella pneumoniae; ecl: Enterobacter cloacae; cfr: Citrobacter freundii; pmi: Proteus mirabilis; mmo: Morganella morganii; sma: Serratia marcescens; aba: Acinetobacter baumannii; pae: Pseudomonas aeruginosa. Note: a. The MIC90 fold reduction for K. pneumoniae is actually ≥ 128, for E. cloacae is actually ≥ 256, for P. mirabilis is actually ≥ 128, for A. baumannii is actually ≥ 4. b. The MIC90 values of ceftazidime and ceftazidime-avibactam for C. freundii are > 128 mg/L and > 64 mg/L. Since they are both off-scale high, this MIC90 comparison wasn’t shown in Fig. 1

Back to article page

BMC Microbiology

ISSN: 1471-2180

Contact us